SertaSil is meant for wounds intended to heal by secondary intention – regardless of aetiology.
SertaSil is intended for wounds characterised by low to high levels of exudate.
SertaSil supports 4 processes in parallel:
- autolytic debridement
- removal of wound infections
- deep tissue tidy-up
- granulation and epithelialisation
SertaSil returns the control of the wound to the immune system.
The immune system can now control the microbiome, i.e. the mini-ecosystem of the wound, and the healing process.
The ingredients of SertaSil are not regulated by the International Doping Agency or FEI. SertaSil is not associated with any withholding times.